The present invention relates to the use of a combination of tetrahydrocannabidiol (THC) and Cannabidiol (CBD) in the treatment of multiple myeloma. The combination of THC and CBD appears to be particularly effective in reducing cell viability and cell migration in this disease. Preferably, the THC and CBD are used in the form of a highly purified extract of cannabis such that the cannabinoids are present at greater than 98% ot the total extract (w/w) and the other components of the extract are characterized. Alternatively, the THC and CBD may be synthetically produced cannabinoid.
Use of Cannabinoids in the treatment of multiple myeloma.
nabissi massimo
2018-01-01
Abstract
The present invention relates to the use of a combination of tetrahydrocannabidiol (THC) and Cannabidiol (CBD) in the treatment of multiple myeloma. The combination of THC and CBD appears to be particularly effective in reducing cell viability and cell migration in this disease. Preferably, the THC and CBD are used in the form of a highly purified extract of cannabis such that the cannabinoids are present at greater than 98% ot the total extract (w/w) and the other components of the extract are characterized. Alternatively, the THC and CBD may be synthetically produced cannabinoid.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
